Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
Pakistan · Delayed Price · Currency is PKR 989.89
-10.41 (-1.04%)
At close: Nov 6, 2026
PSX:ABOT Financials Overview
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 77,827 | 75,398 | 68,177 | 55,475 | 49,258 | 42,570 |
Revenue Growth | 3.99% | 10.59% | 22.90% | 12.62% | 15.71% | 20.65% |
Gross Profit Gross Profit Growth | 29,551 | 26,678 | 19,894 | 11,760 | 14,436 | 16,015 |
Operating Income Operating Income Growth | 15,045 | 12,947 | 8,669 | 2,468 | 6,011 | 8,006 |
Net Income Net Income Growth | 9,285 | 7,967 | 5,234 | 261.78 | 3,004 | 5,967 |
Earnings Per Share EPS Growth | 94.84 | 81.37 | 53.46 | 2.67 | 30.69 | 60.95 |
EPS Growth | 39.61% | 52.20% | 1899.50% | -91.29% | -49.65% | 31.57% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Pharmaceutical Growth | 55,979 | 53,331 | 46,137 | 37,783 | 31,486 | 30,128 |
Nutritional Nutritional Growth | 14,402 | 15,018 | 13,784 | 11,414 | 12,365 | 11,938 |
Diagnostic Diagnostic Growth | 5,675 | 5,344 | 6,537 | 4,774 | 4,133 | 3,803 |
Others Others Growth | 1,771 | 1,705 | 1,720 | 1,504 | 1,274 | 1,311 |
Total Total Growth | 77,827 | 75,398 | 68,177 | 55,475 | 49,258 | 47,180 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 10,375 | 13,338 | 6,182 | 5,037 | 8,792 | 8,619 |
Total Debt Total Debt Growth | 400.8 | 487.98 | 52.23 | 158.22 | 247.29 | 243.46 |
Net Cash (Debt) Net Cash Growth | 9,974 | 12,850 | 6,130 | 4,878 | 8,545 | 8,376 |
Net Cash Growth | 16.32% | 109.61% | 25.66% | -42.91% | 2.01% | 25.53% |
Net Cash Per Share Net Cash Per Share Growth | 101.88 | 131.25 | 62.62 | 49.83 | 87.28 | 85.56 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8,159 | 10,740 | 4,674 | -62.3 | 3,797 | 7,823 |
Capital Expenditures CapEx Growth | -3,523 | -3,299 | -3,022 | -3,075 | -3,585 | -2,055 |
Free Cash Flow Free Cash Flow Growth | 4,636 | 7,441 | 1,652 | -3,137 | 212.23 | 5,768 |
Free Cash Flow Growth | -11.62% | 350.45% | - | - | -96.32% | -14.77% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.97% | 35.38% | 29.18% | 21.20% | 29.31% | 37.62% |
Operating Margin | 19.33% | 17.17% | 12.72% | 4.45% | 12.20% | 18.81% |
Pretax Margin | 20.23% | 17.90% | 13.39% | 4.67% | 12.48% | 19.76% |
Profit Margin | 11.93% | 10.57% | 7.68% | 0.47% | 6.10% | 14.02% |
FCF Margin | 5.96% | 9.87% | 2.42% | -5.65% | 0.43% | 13.55% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 40.000 | 40.000 | 10.000 | - | 15.000 | 40.000 |
Dividend Per Share Growth | 300.00% | 300.00% | - | - | -62.50% | 0% |
Dividend Yield | 4.04% | 3.81% | 0.81% | - | 3.24% | 5.58% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.44 | 12.91 | 23.15 | 172.11 | 15.10 | 11.77 |
Forward PE | 8.69 | 13.14 | 11.12 | 11.12 | 11.12 | 11.43 |
P/FCF Ratio | 20.90 | 13.82 | 73.36 | - | 213.72 | 12.18 |
PS Ratio | 1.25 | 1.36 | 1.78 | 0.81 | 0.92 | 1.65 |